U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT06853665) titled 'The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine' on Feb. 25.
Brief Summary: We are conducting a 10-week brain imaging and medication study. We are doing the research to study the response of ADHD in youth with ASD on extended-release formulation of mixed amphetamine salts (MAS) (also know as Adderall XR). We also want to find out if taking MAS has any effect on the brains of children and adolescents with ADHD and ASD. This study will help researchers better understand how the use of MAS to treat ADHD effects children and adolescents with ASD. We will compare MAS to a placebo. The placebo will look ex...